title: Roles of norepinephrine, free Fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis.
abstract: Thyroid hormone (TH) plays a fundamental role in thermoregulation, yet the molecular mediators of its effects are not fully defined. Recently, skeletal muscle (SKM) uncoupling protein (UCP) 3 was shown to be an important mediator of the thermogenic effects of the widely abused sympathomimetic agents 3,4-methylenedioxymethamphetamine (MDMA; Ecstasy) and methamphetamine. Expression of UCP3 is regulated by TH. Activation of UCP3 is indirectly regulated by norepinephrine (NE) and is dependent upon the availability of free fatty acids (FFAs). We hypothesized that UCP3 may be a molecular link between TH and hyperthermia, requiring increased levels of both NE and FFAs to accomplish the thermogenic effect. Here, we demonstrate that MDMA (40 mg/kg s.c.) significantly increases plasma FFA levels 30 min after treatment. Pharmacologically increasing NE levels through the inhibition of phenylethanolamine N-methyltransferase with +/-2,3-dichloro-alpha-methylbenzylamine potentiated the hyperthermic effects of a 20 mg/kg dose of MDMA. Using Western blots and regression analysis, we further illustrated that chronic hyperthyroidism in rats potentiates the hyperthermic effects of MDMA and increases levels of SKM UCP3 protein in a linear fashion according to levels of circulating plasma TH. Conversely, chronic hypothyroidism results in a hypothermic response to MDMA that is directly proportionate to decreased UCP3 expression. Acute TH supplementation did not change the skeletal muscle UCP3 expression levels or temperature responses to MDMA. These findings suggest that, although MDMA-induced hyperthermia appears to result from increased NE and FFA levels, susceptibility is ultimately determined by TH regulation of UCP3-dependent thermogenesis.
authors.affiliation: The Department of Pharmaceutical and Biomedical Sciences, The Raabe College of Pharmacy, Ohio Northern University, Ada, Ohio, USA.
authors.forename: Jon E
authors.initials: JE
authors.lastname: Sprague
authors.forename: Xianmei
authors.initials: X
authors.lastname: Yang
authors.forename: Joni
authors.initials: J
authors.lastname: Sommers
authors.forename: Tracy L
authors.initials: TL
authors.lastname: Gilman
authors.forename: Edward M
authors.initials: EM
authors.lastname: Mills
mesh_terms: D000818:Animals; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D007473:Ion Channels / Q000032:analysis*; D008297:Male; D024101:Mitochondrial Proteins / Q000032:analysis*; D018482:Muscle, Skeletal / Q000737:chemistry*; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013566:Sympathomimetics / Q000494:pharmacology*; D022722:Thermogenesis / Q000187:drug effects*; D013961:Thyroid Gland / Q000502:physiology*; D013974:Thyroxine / Q000097:blood; D000071247:Uncoupling Protein 3
chemical_list: D005230:Fatty Acids, Nonesterified; D007473:Ion Channels; D024101:Mitochondrial Proteins; D013566:Sympathomimetics; C000604394:Ucp3 protein, rat; D000071247:Uncoupling Protein 3; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D013974:Thyroxine; D009638:Norepinephrine